compounded semaglutide vs compounded tirzepatide vs. Semaglutide vs Tirzepatide - A

AbbVie / Pharmacyclics ($21B, 2015): Valuing the Patent Wall At $21 billion, AbbVie acquired an asset, ibrutinib (Imbruvica), that had generated approximately $1 billion in revenue in its first full year of commercial sale

Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment

[NEJM full text] Katsi V, et al

They act on gut-hormone pathways that regulate appetite, gastric emptying, blood sugar, and energy balance